HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 16-JAN-12 4DBU
TITLE CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5
TITLE 2 (AKR1C3) IN COMPLEX WITH NADP+ AND 3-((4 -(TRIFLUOROMETHYL)PHENYL)
TITLE 3 AMINO)BENZOIC ACID
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: ALDO-KETO REDUCTASE FAMILY 1 MEMBER C3;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: 17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5, 17-BETA-HSD 5,
COMPND 5 3-ALPHA-HSD TYPE II, 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE TYPE 2, 3-
COMPND 6 ALPHA-HSD TYPE 2, CHLORDECONE REDUCTASE HOMOLOG HAKRB, DIHYDRODIOL
COMPND 7 DEHYDROGENASE 3, DD-3, DD3, DIHYDRODIOL DEHYDROGENASE TYPE I, HA1753,
COMPND 8 INDANOL DEHYDROGENASE, PROSTAGLANDIN F SYNTHASE, PGFS, TESTOSTERONE
COMPND 9 17-BETA-DEHYDROGENASE 5, TRANS-1,2-DIHYDROBENZENE-1,2-DIOL
COMPND 10 DEHYDROGENASE;
COMPND 11 EC: 1.1.1.213, 1.1.1.112, 1.1.1.188, 1.1.1.63, 1.1.1.64, 1.3.1.20;
COMPND 12 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 8 EXPRESSION_SYSTEM_STRAIN: C41(DE3);
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET16B
KEYWDS CASTRATE RESISTANT PROSTATE CANCER, AKR1C3 SELECTIVE INHIBITOR, TIM
KEYWDS 2 BARREL, STEROID METABOLISM, OXIDOREDUCTASE-OXIDOREDUCTASE INHIBITOR
KEYWDS 3 COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR M.CHEN,D.W.CHRISTIANSON,J.D.WINKLER,T.M.PENNING
REVDAT 6 13-SEP-23 4DBU 1 REMARK
REVDAT 5 15-NOV-17 4DBU 1 REMARK
REVDAT 4 23-MAY-12 4DBU 1 JRNL
REVDAT 3 02-MAY-12 4DBU 1 JRNL
REVDAT 2 11-APR-12 4DBU 1 REMARK
REVDAT 1 28-MAR-12 4DBU 0
JRNL AUTH M.CHEN,A.O.ADENIJI,B.M.TWENTER,J.D.WINKLER,D.W.CHRISTIANSON,
JRNL AUTH 2 T.M.PENNING
JRNL TITL CRYSTAL STRUCTURES OF AKR1C3 CONTAINING AN
JRNL TITL 2 N-(ARYL)AMINO-BENZOATE INHIBITOR AND A BIFUNCTIONAL AKR1C3
JRNL TITL 3 INHIBITOR AND ANDROGEN RECEPTOR ANTAGONIST. THERAPEUTIC
JRNL TITL 4 LEADS FOR CASTRATE RESISTANT PROSTATE CANCER.
JRNL REF BIOORG.MED.CHEM.LETT. V. 22 3492 2012
JRNL REFN ISSN 0960-894X
JRNL PMID 22507964
JRNL DOI 10.1016/J.BMCL.2012.03.085
REMARK 2
REMARK 2 RESOLUTION. 2.53 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX 1.5_2
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : ML
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.53
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.51
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.100
REMARK 3 COMPLETENESS FOR RANGE (%) : 92.3
REMARK 3 NUMBER OF REFLECTIONS : 21058
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.231
REMARK 3 R VALUE (WORKING SET) : 0.228
REMARK 3 FREE R VALUE : 0.294
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.880
REMARK 3 FREE R VALUE TEST SET COUNT : 1027
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 44.5122 - 4.8343 0.99 3078 140 0.2045 0.2447
REMARK 3 2 4.8343 - 3.8378 0.98 3001 170 0.1911 0.2322
REMARK 3 3 3.8378 - 3.3529 0.98 3017 152 0.2165 0.2950
REMARK 3 4 3.3529 - 3.0464 0.94 2937 149 0.2438 0.3239
REMARK 3 5 3.0464 - 2.8281 0.90 2749 152 0.2513 0.3529
REMARK 3 6 2.8281 - 2.6614 0.87 2715 137 0.2674 0.3397
REMARK 3 7 2.6614 - 2.5280 0.81 2534 127 0.2810 0.3862
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL
REMARK 3 SOLVENT RADIUS : 1.11
REMARK 3 SHRINKAGE RADIUS : 0.90
REMARK 3 K_SOL : 0.31
REMARK 3 B_SOL : 20.81
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.420
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 32.620
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 37.30
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.06
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 14.93030
REMARK 3 B22 (A**2) : -6.22060
REMARK 3 B33 (A**2) : -8.70970
REMARK 3 B12 (A**2) : -3.46910
REMARK 3 B13 (A**2) : 5.31770
REMARK 3 B23 (A**2) : 0.03990
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : 0.003 5341
REMARK 3 ANGLE : 0.631 7251
REMARK 3 CHIRALITY : 0.045 783
REMARK 3 PLANARITY : 0.003 925
REMARK 3 DIHEDRAL : 18.754 2085
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 4DBU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-JAN-12.
REMARK 100 THE DEPOSITION ID IS D_1000070134.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 22-NOV-10
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 6.0
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : NSLS
REMARK 200 BEAMLINE : X29A
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795
REMARK 200 MONOCHROMATOR : SAGITALLY FOCUSED SI(111)
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22331
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.528
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6
REMARK 200 DATA REDUNDANCY : 2.200
REMARK 200 R MERGE (I) : 0.09300
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 6.7000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.53
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.62
REMARK 200 COMPLETENESS FOR SHELL (%) : 97.9
REMARK 200 DATA REDUNDANCY IN SHELL : 2.10
REMARK 200 R MERGE FOR SHELL (I) : 0.31500
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: PDB ENTRY 1S2A
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 48.39
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 15% PEG8000, 0.1 M MES, PH 6.0, VAPOR
REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 1
REMARK 465 ASP A 2
REMARK 465 SER A 3
REMARK 465 LYS A 4
REMARK 465 GLN A 5
REMARK 465 ASP A 321
REMARK 465 GLU A 322
REMARK 465 TYR A 323
REMARK 465 MET B 1
REMARK 465 ASP B 2
REMARK 465 SER B 3
REMARK 465 LYS B 4
REMARK 465 GLN B 5
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASN A 57 3.90 -152.93
REMARK 500 ASP A 132 -177.20 -68.07
REMARK 500 PHE A 197 59.16 -179.00
REMARK 500 SER A 221 174.31 86.86
REMARK 500 LEU A 236 20.64 -71.23
REMARK 500 ARG A 250 -145.76 -129.39
REMARK 500 GLN A 282 2.47 -68.88
REMARK 500 ASN A 302 57.55 32.90
REMARK 500 ARG B 31 -9.61 -59.71
REMARK 500 ASN B 57 11.73 -153.51
REMARK 500 MET B 120 99.40 -68.70
REMARK 500 SER B 129 76.24 -157.96
REMARK 500 PRO B 130 94.97 -61.66
REMARK 500 GLU B 133 -88.63 57.42
REMARK 500 LYS B 179 132.76 -38.93
REMARK 500 PHE B 197 66.76 -168.32
REMARK 500 SER B 221 172.60 77.70
REMARK 500 TRP B 227 -16.23 -145.26
REMARK 500 SER B 271 125.24 -170.25
REMARK 500 ARG B 301 22.32 -145.45
REMARK 500 ASN B 307 78.91 -112.09
REMARK 500 SER B 320 36.24 -97.63
REMARK 500 GLU B 322 95.55 -69.40
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP A 401
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BT9 A 402
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP B 401
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BT9 B 402
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 4DBS RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE
REMARK 900 5 (AKR1C3) IN COMPLEX WITH NADP+ AND 3'-[(4-NITRONAPHTHALEN-1-YL)
REMARK 900 AMINO]BENZOIC ACID
REMARK 999
REMARK 999 SEQUENCE
REMARK 999 H5Q IS A NATURAL VARIANT.
DBREF 4DBU A 1 323 UNP P42330 AK1C3_HUMAN 1 323
DBREF 4DBU B 1 323 UNP P42330 AK1C3_HUMAN 1 323
SEQADV 4DBU GLN A 5 UNP P42330 HIS 5 SEE REMARK 999
SEQADV 4DBU GLN B 5 UNP P42330 HIS 5 SEE REMARK 999
SEQRES 1 A 323 MET ASP SER LYS GLN GLN CYS VAL LYS LEU ASN ASP GLY
SEQRES 2 A 323 HIS PHE MET PRO VAL LEU GLY PHE GLY THR TYR ALA PRO
SEQRES 3 A 323 PRO GLU VAL PRO ARG SER LYS ALA LEU GLU VAL THR LYS
SEQRES 4 A 323 LEU ALA ILE GLU ALA GLY PHE ARG HIS ILE ASP SER ALA
SEQRES 5 A 323 HIS LEU TYR ASN ASN GLU GLU GLN VAL GLY LEU ALA ILE
SEQRES 6 A 323 ARG SER LYS ILE ALA ASP GLY SER VAL LYS ARG GLU ASP
SEQRES 7 A 323 ILE PHE TYR THR SER LYS LEU TRP SER THR PHE HIS ARG
SEQRES 8 A 323 PRO GLU LEU VAL ARG PRO ALA LEU GLU ASN SER LEU LYS
SEQRES 9 A 323 LYS ALA GLN LEU ASP TYR VAL ASP LEU TYR LEU ILE HIS
SEQRES 10 A 323 SER PRO MET SER LEU LYS PRO GLY GLU GLU LEU SER PRO
SEQRES 11 A 323 THR ASP GLU ASN GLY LYS VAL ILE PHE ASP ILE VAL ASP
SEQRES 12 A 323 LEU CYS THR THR TRP GLU ALA MET GLU LYS CYS LYS ASP
SEQRES 13 A 323 ALA GLY LEU ALA LYS SER ILE GLY VAL SER ASN PHE ASN
SEQRES 14 A 323 ARG ARG GLN LEU GLU MET ILE LEU ASN LYS PRO GLY LEU
SEQRES 15 A 323 LYS TYR LYS PRO VAL CYS ASN GLN VAL GLU CYS HIS PRO
SEQRES 16 A 323 TYR PHE ASN ARG SER LYS LEU LEU ASP PHE CYS LYS SER
SEQRES 17 A 323 LYS ASP ILE VAL LEU VAL ALA TYR SER ALA LEU GLY SER
SEQRES 18 A 323 GLN ARG ASP LYS ARG TRP VAL ASP PRO ASN SER PRO VAL
SEQRES 19 A 323 LEU LEU GLU ASP PRO VAL LEU CYS ALA LEU ALA LYS LYS
SEQRES 20 A 323 HIS LYS ARG THR PRO ALA LEU ILE ALA LEU ARG TYR GLN
SEQRES 21 A 323 LEU GLN ARG GLY VAL VAL VAL LEU ALA LYS SER TYR ASN
SEQRES 22 A 323 GLU GLN ARG ILE ARG GLN ASN VAL GLN VAL PHE GLU PHE
SEQRES 23 A 323 GLN LEU THR ALA GLU ASP MET LYS ALA ILE ASP GLY LEU
SEQRES 24 A 323 ASP ARG ASN LEU HIS TYR PHE ASN SER ASP SER PHE ALA
SEQRES 25 A 323 SER HIS PRO ASN TYR PRO TYR SER ASP GLU TYR
SEQRES 1 B 323 MET ASP SER LYS GLN GLN CYS VAL LYS LEU ASN ASP GLY
SEQRES 2 B 323 HIS PHE MET PRO VAL LEU GLY PHE GLY THR TYR ALA PRO
SEQRES 3 B 323 PRO GLU VAL PRO ARG SER LYS ALA LEU GLU VAL THR LYS
SEQRES 4 B 323 LEU ALA ILE GLU ALA GLY PHE ARG HIS ILE ASP SER ALA
SEQRES 5 B 323 HIS LEU TYR ASN ASN GLU GLU GLN VAL GLY LEU ALA ILE
SEQRES 6 B 323 ARG SER LYS ILE ALA ASP GLY SER VAL LYS ARG GLU ASP
SEQRES 7 B 323 ILE PHE TYR THR SER LYS LEU TRP SER THR PHE HIS ARG
SEQRES 8 B 323 PRO GLU LEU VAL ARG PRO ALA LEU GLU ASN SER LEU LYS
SEQRES 9 B 323 LYS ALA GLN LEU ASP TYR VAL ASP LEU TYR LEU ILE HIS
SEQRES 10 B 323 SER PRO MET SER LEU LYS PRO GLY GLU GLU LEU SER PRO
SEQRES 11 B 323 THR ASP GLU ASN GLY LYS VAL ILE PHE ASP ILE VAL ASP
SEQRES 12 B 323 LEU CYS THR THR TRP GLU ALA MET GLU LYS CYS LYS ASP
SEQRES 13 B 323 ALA GLY LEU ALA LYS SER ILE GLY VAL SER ASN PHE ASN
SEQRES 14 B 323 ARG ARG GLN LEU GLU MET ILE LEU ASN LYS PRO GLY LEU
SEQRES 15 B 323 LYS TYR LYS PRO VAL CYS ASN GLN VAL GLU CYS HIS PRO
SEQRES 16 B 323 TYR PHE ASN ARG SER LYS LEU LEU ASP PHE CYS LYS SER
SEQRES 17 B 323 LYS ASP ILE VAL LEU VAL ALA TYR SER ALA LEU GLY SER
SEQRES 18 B 323 GLN ARG ASP LYS ARG TRP VAL ASP PRO ASN SER PRO VAL
SEQRES 19 B 323 LEU LEU GLU ASP PRO VAL LEU CYS ALA LEU ALA LYS LYS
SEQRES 20 B 323 HIS LYS ARG THR PRO ALA LEU ILE ALA LEU ARG TYR GLN
SEQRES 21 B 323 LEU GLN ARG GLY VAL VAL VAL LEU ALA LYS SER TYR ASN
SEQRES 22 B 323 GLU GLN ARG ILE ARG GLN ASN VAL GLN VAL PHE GLU PHE
SEQRES 23 B 323 GLN LEU THR ALA GLU ASP MET LYS ALA ILE ASP GLY LEU
SEQRES 24 B 323 ASP ARG ASN LEU HIS TYR PHE ASN SER ASP SER PHE ALA
SEQRES 25 B 323 SER HIS PRO ASN TYR PRO TYR SER ASP GLU TYR
HET NAP A 401 48
HET BT9 A 402 20
HET NAP B 401 48
HET BT9 B 402 20
HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE
HETNAM BT9 3-{[4-(TRIFLUOROMETHYL)PHENYL]AMINO}BENZOIC ACID
HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE
FORMUL 3 NAP 2(C21 H28 N7 O17 P3)
FORMUL 4 BT9 2(C14 H10 F3 N O2)
FORMUL 7 HOH *163(H2 O)
HELIX 1 1 PRO A 30 GLY A 45 1 16
HELIX 2 2 ASN A 57 ASP A 71 1 15
HELIX 3 3 TRP A 86 HIS A 90 5 5
HELIX 4 4 ARG A 91 GLU A 93 5 3
HELIX 5 5 LEU A 94 ALA A 106 1 13
HELIX 6 6 ASP A 143 ALA A 157 1 15
HELIX 7 7 ASN A 169 ASN A 178 1 10
HELIX 8 8 ARG A 199 LYS A 209 1 11
HELIX 9 9 VAL A 234 GLU A 237 5 4
HELIX 10 10 ASP A 238 HIS A 248 1 11
HELIX 11 11 THR A 251 GLN A 262 1 12
HELIX 12 12 ASN A 273 VAL A 281 1 9
HELIX 13 13 GLN A 282 PHE A 286 5 5
HELIX 14 14 THR A 289 GLY A 298 1 10
HELIX 15 15 SER A 310 HIS A 314 5 5
HELIX 16 16 ARG B 31 GLY B 45 1 15
HELIX 17 17 ALA B 52 ASN B 56 5 5
HELIX 18 18 ASN B 57 ASP B 71 1 15
HELIX 19 19 TRP B 86 HIS B 90 5 5
HELIX 20 20 ARG B 91 GLU B 93 5 3
HELIX 21 21 LEU B 94 GLN B 107 1 14
HELIX 22 22 ASP B 143 ALA B 157 1 15
HELIX 23 23 ASN B 169 LYS B 179 1 11
HELIX 24 24 ARG B 199 SER B 208 1 10
HELIX 25 25 VAL B 234 GLU B 237 5 4
HELIX 26 26 ASP B 238 LYS B 249 1 12
HELIX 27 27 THR B 251 ARG B 263 1 13
HELIX 28 28 ASN B 273 VAL B 281 1 9
HELIX 29 29 GLN B 282 PHE B 286 5 5
HELIX 30 30 THR B 289 GLY B 298 1 10
SHEET 1 A 2 CYS A 7 LYS A 9 0
SHEET 2 A 2 PHE A 15 PRO A 17 -1 O MET A 16 N VAL A 8
SHEET 1 B 9 LEU A 19 GLY A 22 0
SHEET 2 B 9 HIS A 48 ASP A 50 1 O ASP A 50 N PHE A 21
SHEET 3 B 9 PHE A 80 LEU A 85 1 O PHE A 80 N ILE A 49
SHEET 4 B 9 LEU A 113 ILE A 116 1 O LEU A 115 N LEU A 85
SHEET 5 B 9 ILE A 163 SER A 166 1 O GLY A 164 N TYR A 114
SHEET 6 B 9 CYS A 188 GLU A 192 1 O CYS A 188 N VAL A 165
SHEET 7 B 9 VAL A 212 TYR A 216 1 O VAL A 214 N VAL A 191
SHEET 8 B 9 VAL A 266 LYS A 270 1 O VAL A 266 N ALA A 215
SHEET 9 B 9 LEU A 19 GLY A 22 1 N GLY A 20 O ALA A 269
SHEET 1 C 2 CYS B 7 LYS B 9 0
SHEET 2 C 2 PHE B 15 PRO B 17 -1 O MET B 16 N VAL B 8
SHEET 1 D 9 LEU B 19 GLY B 22 0
SHEET 2 D 9 HIS B 48 ASP B 50 1 O HIS B 48 N PHE B 21
SHEET 3 D 9 PHE B 80 LEU B 85 1 O PHE B 80 N ILE B 49
SHEET 4 D 9 VAL B 111 ILE B 116 1 O LEU B 115 N LEU B 85
SHEET 5 D 9 ALA B 160 SER B 166 1 O LYS B 161 N VAL B 111
SHEET 6 D 9 CYS B 188 GLU B 192 1 O GLN B 190 N VAL B 165
SHEET 7 D 9 VAL B 212 TYR B 216 1 O VAL B 214 N VAL B 191
SHEET 8 D 9 VAL B 266 LYS B 270 1 O VAL B 266 N ALA B 215
SHEET 9 D 9 LEU B 19 GLY B 22 1 N GLY B 20 O VAL B 267
SHEET 1 E 2 THR B 131 ASP B 132 0
SHEET 2 E 2 LYS B 136 VAL B 137 -1 O LYS B 136 N ASP B 132
SITE 1 AC1 25 GLY A 22 THR A 23 TYR A 24 ASP A 50
SITE 2 AC1 25 TYR A 55 HIS A 117 SER A 166 ASN A 167
SITE 3 AC1 25 GLN A 190 TYR A 216 SER A 217 LEU A 219
SITE 4 AC1 25 SER A 221 GLN A 222 ALA A 253 LYS A 270
SITE 5 AC1 25 SER A 271 TYR A 272 ARG A 276 GLN A 279
SITE 6 AC1 25 ASN A 280 BT9 A 402 HOH A1021 HOH A1022
SITE 7 AC1 25 HOH A1027
SITE 1 AC2 9 TYR A 24 TYR A 55 HIS A 117 MET A 120
SITE 2 AC2 9 ASN A 167 TYR A 216 PHE A 306 PRO A 318
SITE 3 AC2 9 NAP A 401
SITE 1 AC3 26 GLY B 22 THR B 23 TYR B 24 ASP B 50
SITE 2 AC3 26 TYR B 55 LYS B 84 HIS B 117 SER B 166
SITE 3 AC3 26 ASN B 167 GLN B 190 TYR B 216 SER B 217
SITE 4 AC3 26 LEU B 219 SER B 221 GLN B 222 ALA B 253
SITE 5 AC3 26 LEU B 268 LYS B 270 SER B 271 TYR B 272
SITE 6 AC3 26 ARG B 276 GLN B 279 ASN B 280 BT9 B 402
SITE 7 AC3 26 HOH B1005 HOH B1056
SITE 1 AC4 12 TYR B 24 LEU B 54 TYR B 55 HIS B 117
SITE 2 AC4 12 SER B 118 MET B 120 ASN B 167 TRP B 227
SITE 3 AC4 12 PHE B 306 TYR B 319 NAP B 401 HOH B1044
CRYST1 47.268 49.136 84.725 71.90 81.58 70.26 P 1 2
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.021156 -0.007592 -0.001044 0.00000
SCALE2 0.000000 0.021622 -0.006320 0.00000
SCALE3 0.000000 0.000000 0.012431 0.00000